PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 31 filers reported holding PROTARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,151 | -34.2% | 78,518 | -5.9% | 0.00% | – |
| Q2 2023 | $199,373 | -22.9% | 83,420 | 0.0% | 0.00% | – |
| Q1 2023 | $258,602 | +115865.0% | 83,420 | 0.0% | 0.00% | – |
| Q4 2022 | $223 | -99.9% | 83,420 | -0.3% | 0.00% | – |
| Q3 2022 | $247,000 | +0.8% | 83,644 | 0.0% | 0.00% | – |
| Q2 2022 | $245,000 | -41.4% | 83,644 | +2.0% | 0.00% | – |
| Q1 2022 | $418,000 | -21.6% | 81,964 | +3.7% | 0.00% | – |
| Q4 2021 | $533,000 | -2.4% | 79,017 | 0.0% | 0.00% | – |
| Q3 2021 | $546,000 | -32.4% | 79,017 | -4.8% | 0.00% | – |
| Q2 2021 | $808,000 | -53.8% | 82,985 | -25.3% | 0.00% | – |
| Q1 2021 | $1,748,000 | -31.2% | 111,062 | +5.9% | 0.00% | – |
| Q4 2020 | $2,539,000 | +644.6% | 104,880 | +417.1% | 0.00% | – |
| Q3 2020 | $341,000 | -33.3% | 20,282 | +16.3% | 0.00% | – |
| Q2 2020 | $511,000 | – | 17,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,674,031 | $13,664,000 | 4.24% |
| Ikarian Capital, LLC | 296,426 | $1,515,000 | 0.20% |
| DLD Asset Management, LP | 229,531 | $1,173,000 | 0.07% |
| Orbimed Advisors | 830,641 | $4,245,000 | 0.07% |
| Boxer Capital, LLC | 209,227 | $1,069,000 | 0.06% |
| Perceptive Advisors | 383,526 | $1,960,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $327,000 | 0.01% |
| Baker Brothers Advisors | 199,671 | $1,020,000 | 0.01% |
| Trexquant Investment LP | 16,313 | $83,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,591 | $141,000 | 0.00% |